
ALT A line graph shows the percent change in triglyceride levels over 24 weeks. There are four lines: placebo (grey), MAR001 300 mg (purple), MAR001 450 mg (light blue), and MAR001 900 mg (dark blue), each starting at zero. Standard error bars are included. Below, a table lists the number of participants for each group at various time points.

ALT A graph from the Original Article "Left Bundle-Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block.” The trial name, OptimPacing, is in parentheses after the title. The graph shows the primary outcome. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

ALT A graph from the Original Article "Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke.” The trial name, OPTIMAL-STROKE, is in parentheses after the title. The graph shows the cumulative hazard of the primary outcome. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

ALT A graph from the Original Article "Discontinuing Statins in Older Adults without Cardiovascular Disease." The trial name, STREAM, is in parentheses after the title. The graph shows estimated cumulative incidence of primary-outcome events. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

































